Crowdonomics
All companies
Care Angel logo

Care Angel

Operating

CARE ANGEL, INC.

Healthcare · Miami, FL · Founded 2014

On a Global Mission to Empower Millions of People to Take Better Care

Post-money valuation ⓘ
$46.0M
As of Jul 2021 · from Reg CF Offering (2020) · pre-money + amount raised, not a traded price
Total raised
$35,222,866
Crowd $251K · Private $35.0M · 13 rounds since 2014
Latest share price
$0.1944
Section 4(a)(2) · Class S Preferred · Feb 2023 offering price

Financials

FY2018–FY2023 · from SEC filings · hover any figure for its source
$78K
−$1.9M
2018
$996K
−$1.7M
2019
$1.5M
−$2.3M
2020
$2.0M
−$3.7M
2021
$1.2M
−$6.9M
2022
$2.0M
−$6.1M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 reviewed
FY2019 reviewed
FY2020
FY2021
FY2022 audited
FY2023 audited
Income statement
Revenue
$78,144
$996,230
$1,532,045
$2,001,567
$1,192,968
$2,000,176
Cost of goods sold
$0
$2,290,299
$845,619
$1,437,383
$1,161,915
$1,131,530
Gross margin
100%
-130%
45%
28%
3%
43%
Net income
-$1,881,801
-$1,654,724
-$2,275,314
-$3,738,087
-$6,865,035
-$6,074,029
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$435,956
$47,581
$42,617
$902,186
$293,659
$1,529,942
Accounts receivable
$52,350
$484,971
$35,834
$251,427
$58,481
$679,684
Total assets
$709,044
$786,269
$321,676
$1,877,739
$897,181
$2,275,735
Short-term debt
$36,831
$61,292
$105,203
$629,975
$1,027,703
$556,691
Long-term debt
$5,617,946
$165,931
$154,240
$0
$0
$295,544
Total liabilities
$5,654,777
$227,223
$259,443
$629,975
$1,027,703
$852,235
Other
Headcount
—
16
16
16
19
20

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$881K
est. pre-money
$881K
est. pre-money
$881K
est. pre-money
$45.7M
pre-money
$17.8M
est. pre-money
$15.5M
est. pre-money
$4.1M
est. pre-money
Section 4(a)(2) · Class Common Stock A · Nov 2019
Section 4(a)(2) · Class A Common · Oct 2019
Rule 506(b) · Common · Oct 2019
Reg CF · Common · Nov 2020
Section 4(a)(2) · Class A Common · Jan 2021
Section 4(a)(2) · Class A Common · Jan 2022
Section 4(a)(2) · Class S Preferred · Feb 2023

Blue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Share price over rounds

log scale
$2.41$0.1552$0.01
Jun 2014Feb 2023
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines, and each class is drawn as its own line.

Cap table

Share counts as of Dec 31, 2023

These classes don't convert into each other and last sold at very different prices, so their share counts can't be added up into ownership percentages. Compare them by price instead.

ClassOutstandingVotes / shareVotesLast price
Series A preferred stockpreferred27,697,388—53.9%—
Preferred Stockpreferred9,862,230—19.2%—
Class A Common Stock13,845,960126.9%$2.41Jul 2022
Class B Common Stock766,956none0%$0.01Oct 2016

Principal holders% as the filing states it, Apr 25, 2023

  • A Technology Company, Inc.3,500,000 Class A Common Stock24.5%of Class A
  • A Technology Company, Inc.48,945 Class B Common Stock24.5%of Class B
  • A Technology Company, Inc.1,662,120 Series Seed Preferred Stock24.5%of Series Seed Preferred

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $7.5MEst. pre-money $4.1M
Raised $4.6MEst. pre-money $15.5M
Raised $3.8MEst. pre-money $17.8M
Raised $250.7K / $1.1MInvestors 341Post-money $46M
Raised $7.3MInvestors 52
Raised $1.7MInvestors 5Est. pre-money $881.4K
Raised $525.1KEst. pre-money $881.4K
Raised $50KEst. pre-money $881.4K
Raised $1.7MInvestors 1

Team

7 people
Wolf ShlagmanFounder
CEO, Chief Angel

Creative Technologist, Founder of Consult A Doctor, 2007. Led Teladoc (TDOC), acquired by KPCB portfolio company in Q4 2013. Over 20 years experience designing products and managing teams.

Darren Hay
Chief Revenue Officer

Former VP with $12B Telus. SVP with $10B ADT/Ideal Life Governor appointed member of Florida state "Telehealth Advisory Council".

Kelly Gregorakis
VP of Marketing

Strategic / growth marketer. B2B leadership Teladoc (TDOC). Specialty in healthcare technology companies

Lena Nikolnikov
VP Product & Clinical Solutions

Extensive acute clinical care, informatics, operations and administrative experience. 16 year career experience. Specialty in healthcare technology operations and product development.

Alma E Lebron
Principal Financial Officer and Principal Accounting Officer
Jason Hendeles
Board Member

Jason Hendeles is a long time investor and tech innovation evangelist with with unique experience in the healthcare IT, aging in place market with consumer facing health monitoring and engagement solutions. He is passionate champion for caregivers and solutions to improve how we care. He serves on the Care Angel Board of Directors.

Patrick Byrne
Board Member

Patrick Byrne, is an long time investor in innovative and disruptive tech companies. He is a board member for several capital and technology companies, including Care Angel. He has a long career as a senior executive leading such companies as Accenture, Ernst and Young and COO of A.T. Kearney, a global management company with thousands of employees world wide .

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not required3+ reports filed & assets ≤ $10M

Filed 4 of 6 annual reports (FY2020–FY2025)

341 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-ARApr 24, 20240001679968-24-000002
    EDGAR
  • Form C-ARApr 25, 20230001679968-23-000002
    EDGAR
  • Form DMar 10, 20230001679968-23-000001
    EDGAR
  • Form DAug 24, 20220001679968-22-000004
    EDGAR
  • Form C-ARApr 27, 20220001665160-22-000941
    EDGAR
  • Form C-AR/AJul 30, 20210001665160-21-001378
    EDGAR
  • Form C-UJul 19, 20210001665160-21-001266
    EDGAR
  • Form C/AJul 7, 20210001665160-21-001214
    EDGAR
Source: ManualCIK 0001679968DEShare price $0.1944

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.